JP2007197346A - Stabilization agent for s-adenosylmethionine and stabilization method for the same - Google Patents
Stabilization agent for s-adenosylmethionine and stabilization method for the same Download PDFInfo
- Publication number
- JP2007197346A JP2007197346A JP2006016595A JP2006016595A JP2007197346A JP 2007197346 A JP2007197346 A JP 2007197346A JP 2006016595 A JP2006016595 A JP 2006016595A JP 2006016595 A JP2006016595 A JP 2006016595A JP 2007197346 A JP2007197346 A JP 2007197346A
- Authority
- JP
- Japan
- Prior art keywords
- sam
- adenosylmethionine
- acid
- extract
- phosphoric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本発明は、S−アデノシルメチオニンを安定化させるための安定剤及び安定化方法に関する。 The present invention relates to a stabilizer and a stabilization method for stabilizing S-adenosylmethionine.
S-アデノシルメチオニン(SAM)は、近年、アルコール性肝炎その他肝臓疾患に顕著な治癒、予防効果のあることで注目されている。さらに、うつ病に対する治癒効果、骨関節症での機能回復効果、老人性痴呆症の改善効果なども報告されている(特許文献1)。 In recent years, S-adenosylmethionine (SAM) has attracted attention because of its remarkable curative and preventive effects on alcoholic hepatitis and other liver diseases. Furthermore, a healing effect for depression, a function recovery effect in osteoarthritis, an improvement effect on senile dementia, and the like have been reported (Patent Document 1).
このSAMは酵母、その中でも清酒酵母など醸造酵母が高生産する能力のあることが知られている。しかしながら、SAMは化学的に不安定な物質であり、常温においても急速に分解が進むため、SAMの効用が注目されながらも、医薬品やサプリメントとして利用する際の大きな障害となっている。米国などでは、SAMのトシル酸塩やパラトルエンスルフォン酸塩、スルフォサルチル酸塩とすることで安定化させ、一部使用されているが、これらは食品添加物として認められているものではなく、SAMをより安全なサプリメントや食品の一部として利用することができるための安定化方法がなにより望まれている。このようなSAMの安定化方法として、トレハロースに、SAMを安定化させる効果のあることが報告されている(Biochemica et Biophysica Acta, 1573 (2002) pp.105-108)。また、塩酸塩の形とすることにより安定化させて販売されているSAMも多い。しかし、これらの安定化効果は十分なものではなく、より安定度の高い方法の開発が必要である。 This SAM is known to have the ability to produce high yields of yeasts, especially brewing yeasts such as sake yeast. However, since SAM is a chemically unstable substance and rapidly decomposes even at room temperature, it has been a major obstacle when used as a pharmaceutical or a supplement, although the utility of SAM is attracting attention. In the US, etc., SAM tosylate, paratoluene sulfonate, and sulfosartylate are stabilized and partially used, but these are not recognized as food additives. A stabilization method for enabling SAM to be used as a safer supplement or part of food is more desirable. As such a SAM stabilization method, it has been reported that trehalose has an effect of stabilizing SAM (Biochemica et Biophysica Acta, 1573 (2002) pp.105-108). There are also many SAMs that are stabilized and sold in the form of hydrochloride. However, these stabilizing effects are not sufficient, and development of a method with higher stability is necessary.
従って、本発明の目的は、SAMを安定化させる効果を有する物質を含有する安定化剤及び該物質を用いた安定化方法を提供することである。 Accordingly, an object of the present invention is to provide a stabilizer containing a substance having an effect of stabilizing SAM and a stabilization method using the substance.
本願発明者らは、鋭意研究の結果、リン酸化合物にSAMを長期にわたって安定化させる効果があることを見出し、本願発明を完成した。 As a result of intensive studies, the present inventors have found that a phosphate compound has an effect of stabilizing SAM over a long period of time, and have completed the present invention.
すなわち、本発明は、リン酸化合物を有効成分として含有するS−アデノシルメチオニンの安定剤を提供する。また、本発明は、S−アデノシルメチオニンにリン酸化合物を添加することを含むS−アデノシルメチオニンの安定化方法を提供する。 That is, the present invention provides a stabilizer for S-adenosylmethionine containing a phosphate compound as an active ingredient. The present invention also provides a method for stabilizing S-adenosylmethionine, which comprises adding a phosphate compound to S-adenosylmethionine.
本発明により、従来の方法よりも長期間にわたって効果的にSAMを安定化させることができる安定剤及び安定化方法が提供された。本発明の安定剤及び安定化方法に用いられるリン酸化合物は、食品添加物としても認められているので、本発明によればSAMをサプリメントや食品の一部としてより安全に利用することができる。本発明は、肝臓疾患、うつ病、骨関節症、老人性痴呆症など様々な効用が明らかでありながら、その実利用が困難であったSAMについての利用の道を拓くものである。 According to the present invention, a stabilizer and a stabilization method capable of stabilizing SAM more effectively over a longer period than conventional methods are provided. Since the phosphate compound used in the stabilizer and stabilization method of the present invention is also recognized as a food additive, according to the present invention, SAM can be used more safely as a supplement or part of food. . The present invention pioneers the use of SAM which has been difficult to use in practice, although various effects such as liver disease, depression, osteoarthritis, and senile dementia are obvious.
本発明の安定剤及び安定化方法で用いられるリン酸化合物は、構造式中にH2PO4−を有する化合物若しくは水に溶解してH2PO4−を有する化合物を生じる化合物又はこれらの塩を言う。具体的には、メタリン酸(HPO3)、リン酸(オルトリン酸、H3PO4)、ピロリン酸(H2PO4−H2PO3)、ポリリン酸(H2PO4−(HPO3)n−2−H2PO3(n≧3))、及びこれらの塩が挙げられる。これらのうち、リン酸、ピロリン酸及びポリリン酸が好ましく、また前記の塩としてはアルカリ金属塩が好ましいが、これらに限定されない。なお、2分子以上のリン酸が脱水縮合した構造の化合物を総称してポリリン酸と言い得るが、本明細書においては、2分子のリン酸が脱水縮合した構造のものをピロリン酸、3分子以上のリン酸が脱水縮合した構造のものをポリリン酸と表現する。なお、上記リン酸化合物は、単独で用いることも2種以上を併用することも可能である。 The phosphoric acid compound used in the stabilizer and stabilization method of the present invention is a compound that has H 2 PO 4- in the structural formula or a compound that dissolves in water to give a compound having H 2 PO 4- or a salt thereof. Say. Specifically, metaphosphoric acid (HPO 3), phosphoric acid (orthophosphoric acid, H 3 PO 4), pyrophosphoric acid (H 2 PO 4 -H 2 PO 3), polyphosphoric acid (H 2 PO 4 - (HPO 3) n-2- H 2 PO 3 (n ≧ 3)) and salts thereof. Of these, phosphoric acid, pyrophosphoric acid, and polyphosphoric acid are preferable, and the above-mentioned salt is preferably an alkali metal salt, but is not limited thereto. A compound having a structure in which two or more molecules of phosphoric acid are dehydrated and condensed can be collectively referred to as polyphosphoric acid. In this specification, a compound having a structure in which two molecules of phosphoric acid are dehydrated and condensed is referred to as pyrophosphoric acid, three molecules. A structure in which the above phosphoric acid is dehydrated and condensed is expressed as polyphosphoric acid. In addition, the said phosphoric acid compound can be used individually or can use 2 or more types together.
本発明の安定剤は、上記のリン酸化合物を有効成分として含有するものである。該安定剤は、粉末若しくは顆粒などの固体又は水溶液等の溶液の形態で調製し得る。固体の場合は、後述する通り、例えばSAMを含む溶液に添加し溶解して用いることができる。安定剤を使用する際には、安定剤中に含まれるリン酸化合物重量がSAM重量に対して好ましくは1〜100倍量、より好ましくは5〜20倍量となるように用いる。例えば、本発明の安定剤を10倍量で用いる場合、安定化させるSAMを含む溶液中のSAM濃度が0.2mg/mlであれば、該SAM溶液1mlに対しリン酸化合物が2mgとなる量の安定剤を用いる。 The stabilizer of the present invention contains the above phosphoric acid compound as an active ingredient. The stabilizer can be prepared in the form of a solid such as a powder or granules or a solution such as an aqueous solution. In the case of a solid, as described later, for example, it can be added to a solution containing SAM and dissolved. When the stabilizer is used, it is used so that the weight of the phosphate compound contained in the stabilizer is preferably 1 to 100 times, more preferably 5 to 20 times the SAM weight. For example, when the stabilizer of the present invention is used in a 10-fold amount, if the SAM concentration in the solution containing SAM to be stabilized is 0.2 mg / ml, the amount of phosphate compound is 2 mg per 1 ml of the SAM solution. Use stabilizers.
本発明によって安定化されるSAMは、特に限定されないが、酵母等のSAM産生能を有する微生物から抽出されたものであり得る。抽出物は、水溶液等の溶液形態であってもよく、また、該抽出物を凍結乾燥又は乾燥させた固体形態であってもよい。該抽出物が溶液形態の場合には、溶液形態の本発明の安定剤を該抽出物に添加して混合することにより、該抽出物中のSAMを安定化させることができる。また、固体形態の本発明の安定剤を溶液形態の該抽出物に添加して溶解させることによっても、該抽出物中のSAMを安定化させることができる。該抽出物が固体形態の場合には、溶液形態の本発明の安定剤中に該抽出物を添加して溶解させるか、又は固体形態の本発明の安定剤と該抽出物とをあらかじめ混合して若しくは順次水などの溶媒に溶解させることにより、該抽出物中のSAMを安定化させることができる。なお、本発明の安定剤を溶液形態にする場合、溶媒としては、リン酸化合物を溶解することができ、人体に無害な溶媒であれば特に限定されないが、安全性及びコストの点から水が好ましい。 The SAM stabilized by the present invention is not particularly limited, but may be extracted from a microorganism having SAM production ability such as yeast. The extract may be in the form of a solution such as an aqueous solution, or in the form of a solid obtained by freeze-drying or drying the extract. When the extract is in a solution form, the SAM in the extract can be stabilized by adding the stabilizer of the present invention in a solution form to the extract and mixing. The SAM in the extract can also be stabilized by adding the solid form of the stabilizer of the present invention to the extract in the form of a solution and dissolving it. When the extract is in solid form, the extract is added and dissolved in the stabilizer of the present invention in solution form, or the solid stabilizer of the present invention and the extract are mixed in advance. Alternatively, the SAM in the extract can be stabilized by dissolving in a solvent such as water. When the stabilizer of the present invention is in the form of a solution, the solvent is not particularly limited as long as it is a solvent that can dissolve a phosphate compound and is harmless to the human body, but water is used from the viewpoint of safety and cost. preferable.
本発明により安定化されたSAMは、液体状態のままでも長期にわたり良好に保存することができる。また、液体状態の該安定化されたSAMを凍結乾燥又は乾燥させることにより固体状態とした場合でも、良好に保存することができる。 The SAM stabilized according to the present invention can be well stored for a long time even in a liquid state. Moreover, even when the stabilized SAM in a liquid state is freeze-dried or dried to obtain a solid state, it can be stored well.
以下、本発明を実施例に基づき具体的に説明する。ただし、本発明は下記実施例に限定されるものではない。 Hereinafter, the present invention will be specifically described based on examples. However, the present invention is not limited to the following examples.
1.SAMの生産及び抽出
まず、酵母Saccharomyces cerevisiae K-9 (協会9号清酒酵母)を、YPD培地(酵母エキス1%、ペプトン2%、グルコース2%) を培養液として用いて、5 ml L字管にて30℃、24時間、振とうして前培養を行った。その後、ショ糖5%、酵母エキス0.3%、KH2PO4 0.4%、K2HPO4 0.2%、MgSO4・7H20 0.05%、L-メチオニン0.15%よりなる培地(以下D培地と称する) 78mlに、OD660=0.1となるように、前培養した酵母菌体を植菌し、200ml容量バッフル付三角フラスコにて、30℃、2日間、振とう培養した。このようにしてSAMを多く生産蓄積させた酵母菌体を培養後、遠心分離により回収し、菌体を滅菌水にて2回洗浄した。
1. Production and extraction of SAM First, 5 ml L-shaped tube using yeast Saccharomyces cerevisiae K-9 (Association No. 9 sake yeast) and YPD medium (
この洗浄菌体を10 mlの滅菌水に懸濁し、-30℃にて一晩凍結後、翌日それを溶解する操作により、SAMを菌体より水抽出することを行った。続いて、遠心にて上清を回収し、それを0.2μmのメンブランフィルターでろ過し、酵母菌体により生産されたSAMの抽出物を得た。 The washed cells were suspended in 10 ml of sterilized water, frozen overnight at −30 ° C., and then dissolved the next day to extract SAM from the cells. Subsequently, the supernatant was collected by centrifugation and filtered through a 0.2 μm membrane filter to obtain an extract of SAM produced by yeast cells.
2.SAM分析
SAMの分析は以下の要領でキャピラリー電気泳動法により測定した。分析条件は以下のとおり。
分析装置
キャピラリーイオンアナライザー(Waters)
分析条件
キャピラリー:AccuSep、 75μm×60 cm
バッファー:40mM リン酸ナトリウムバッファー (pH 2.5)
電圧:positive、20 kV
サンプリング:30秒ハイドロスタティック法
温度:25℃
検出 :UV 254nm
2. SAM analysis SAM analysis was measured by capillary electrophoresis in the following manner. The analysis conditions are as follows.
Analyzer Capillary ion analyzer (Waters)
Analysis conditions Capillary: AccuSep, 75μm × 60 cm
Buffer: 40 mM sodium phosphate buffer (pH 2.5)
Voltage: positive, 20 kV
Sampling: 30 seconds hydrostatic method Temperature: 25 ℃
Detection: UV 254nm
3.SAM安定性試験(その1)(凍結乾燥保存)
前記のSAM抽出物(0.2mg/ml)に、安定化試験に供する物質をSAM重量の10倍量添加し、それぞれを一定量ずつ小分けし、その後凍結乾燥を行った。そのSAMと添加物質とからなる凍結乾燥物を25℃、および37℃に暗所保存し、経時的にSAMの残存量を測定した。これにより、各種添加物質の乾燥状態におけるSAMの安定保存状態を調べた。なお、独立した試験をそれぞれ3回行った。
3. SAM stability test (part 1) (freeze-dried storage)
To the SAM extract (0.2 mg / ml), a substance to be subjected to the stabilization test was added in an amount 10 times the SAM weight, and each was subdivided into a predetermined amount, and then lyophilized. The lyophilized product composed of the SAM and the additive substance was stored in the dark at 25 ° C. and 37 ° C., and the remaining amount of SAM was measured over time. Thereby, the stable preservation | save state of SAM in the dry state of various additive substances was investigated. Each independent test was performed three times.
(i) 酵母から抽出したSAMをそのまま凍結乾燥したもの(図1中「原液」と表示)、(ii) 希塩酸を0.1N HClとなるよう添加したあと凍結乾燥したもの(「0.1N HCl」と表示)、及び(iii)リン酸をSAM重量の10倍量、つまり市販のリン酸は85%純度であることより、SAM抽出物(0.2mg/ml)に1 mlあたり2.42mg添加し凍結乾燥したもの(「リン酸」と表示)、の3つにつき、保存開始直後を0日、その後37℃にて暗所保存3日目、1週間目、1ヶ月目でのSAM残存量を調べた結果を図1に示した。
(i) The SAM extracted from yeast was lyophilized as it was (indicated as “stock solution” in FIG. 1), and (ii) lyophilized after addition of dilute hydrochloric acid to 0.1N HCl (“0.1N HCl”) Display), and (iii) 10 times the SAM weight of phosphoric acid, that is, commercially available phosphoric acid is 85% pure, so 2.42 mg per ml was added to the SAM extract (0.2 mg / ml) and lyophilized. The remaining amount of SAM was examined for the three samples (labeled “phosphoric acid”) immediately after the start of storage on
SAMは試薬として塩酸塩の形で販売されているものが多い。塩酸塩の形では、確かに抽出物そのままで凍結保存したものより安定であることが示されたが、リン酸を添加しリン酸塩とした状態では、塩酸塩よりさらに安定に保存されていることが示された。 Many SAMs are sold in the form of hydrochloride as a reagent. In the form of hydrochloride, it was certainly shown that the extract was more stable than the one that was cryopreserved as it was, but in the state where phosphoric acid was added to form phosphate, it was stored more stably than the hydrochloride. It was shown that.
SAM安定性試験(その2)(凍結乾燥保存)
(i) 酵母から抽出したSAMをそのまま凍結乾燥したもの(図2中「原液」と表示)、(ii) 添加によりSAMの保存性が向上するとの報告のあるトレハロースをSAM重量の10倍量(SAM抽出物(0.2mg/ml) 1 ml当たり2.0mg)添加し凍結乾燥したもの、および(iii) ポリリン酸混合物(ピロリン酸85.8%含有)をSAM重量の10倍量(SAM抽出物(0.2mg/ml) 1 ml当たり2.0mg)添加し凍結乾燥したものの3つにつき、37℃にて1週間、1ヶ月、3ヶ月間のSAM保存試験を行った結果を図2に示す。
SAM stability test (2) (freeze-dried storage)
(i) The SAM extracted from yeast was lyophilized as it was (designated as “stock solution” in FIG. 2), and (ii) 10 times the SAM weight of trehalose reported to improve the storage stability of SAM when added ( SAM extract (0.2 mg / ml) added and freeze-dried (2.0 mg), and (iii) polyphosphoric acid mixture (containing 85.8% pyrophosphate) 10 times the SAM weight (SAM extract (0.2 mg FIG. 2 shows the results of a SAM storage test conducted at 37 ° C. for one week, one month, and three months for three of those added and lyophilized at 2.0 mg / ml).
上記試験の結果、トレハロースには保存性を増大させる効果は認められなかった。一方、ポリリン酸混合物の場合は、3ヶ月後もほぼ100%近くSAMが残存しており、極めて良好なSAM保存効果が認められた。 As a result of the above test, trehalose did not have an effect of increasing the storage stability. On the other hand, in the case of the polyphosphoric acid mixture, almost 100% of SAM remained even after 3 months, and a very good SAM storage effect was observed.
以上、図1及び2に示したように、リン酸化合物、特にピロリン酸を主に含有するポリリン酸混合物にSAM乾燥状態で高い保存性が確認された。 As described above, as shown in FIGS. 1 and 2, high storage stability was confirmed in a SAM dry state in a polyphosphoric acid mixture mainly containing a phosphoric acid compound, particularly pyrophosphoric acid.
SAM安定性試験(その3)(水溶液保存)
前記のSAM抽出物に、安定化試験に供する物質をSAM重量の10倍量添加し、それぞれを一定量ずつ小分けし、その後水溶液の状態で、37℃に暗所保存し、経時的にSAMの残存量を測定した。これにより、各種添加物質の水溶液状態におけるSAMの安定保存状態を調べた。なお、独立した試験をそれぞれ3回行った。
SAM stability test (Part 3) (Aqueous solution storage)
To the SAM extract, 10 times the SAM weight of the substance to be used for the stabilization test was added, and each aliquot was aliquoted, then stored in the dark at 37 ° C. in the form of an aqueous solution. The remaining amount was measured. Thereby, the stable preservation | save state of SAM in the aqueous solution state of various additive substances was investigated. Each independent test was performed three times.
(i) 酵母から抽出したSAM含有水溶液(SAM量2mg/ml)(図3中「原液」と表示)、(ii) ポリリン酸ナトリウムをSAMの10倍量(すなわち20mg/ml量となるように)添加したもの、及び(iii) ピロリン酸ナトリウムをSAMの10倍量(20mg/ml量)添加したものを、そのまま37℃にて暗所保存した時の、1週間、1ヶ月、3ヶ月目のSAM残存率を図3に示す。
(i) SAM-containing aqueous solution extracted from yeast (SAM amount 2 mg / ml) (indicated as “stock solution” in FIG. 3), (ii) sodium polyphosphate 10 times the amount of SAM (
酵母から抽出したSAMそのものでは、1ヶ月あまりでSAMがほぼ完全に分解消失していた。これに対し、ポリリン酸ナトリウム添加では3ヶ月後も80%以上、さらにピロリン酸ナトリウムにおいてはほぼ100%のSAMが残存しており、水溶液状態でも安定したSAM保存性を示すことが認められた。 In the SAM itself extracted from yeast, the SAM was almost completely decomposed and disappeared in about one month. On the other hand, when sodium polyphosphate was added, 80% or more of SAM remained after 3 months, and almost 100% of SAM remained in sodium pyrophosphate. It was confirmed that stable SAM storage stability was exhibited even in an aqueous solution state.
Claims (11)
The extract from the microorganism is in the form of a solution, a lyophilized product or a dried product, and the phosphate compound is added to the extract and maintained in a solution state or the phosphate compound is added to the extract. The method according to claim 10, wherein the added solution is lyophilized or dried to maintain the solid state.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006016595A JP5046077B2 (en) | 2006-01-25 | 2006-01-25 | Method for stabilizing S-adenosylmethionine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006016595A JP5046077B2 (en) | 2006-01-25 | 2006-01-25 | Method for stabilizing S-adenosylmethionine |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007197346A true JP2007197346A (en) | 2007-08-09 |
JP5046077B2 JP5046077B2 (en) | 2012-10-10 |
Family
ID=38452309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006016595A Expired - Fee Related JP5046077B2 (en) | 2006-01-25 | 2006-01-25 | Method for stabilizing S-adenosylmethionine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5046077B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010007651A1 (en) * | 2008-07-15 | 2010-01-21 | リジェンティス株式会社 | Composition having anti-periodontal disease effect |
WO2013080265A1 (en) * | 2011-12-02 | 2013-06-06 | 磐田化学工業株式会社 | Stabilization of s-adenosylmethionine with acid sodium metaphosphate |
WO2013146687A1 (en) * | 2012-03-30 | 2013-10-03 | ライオン株式会社 | Composition comprising s-adenosylmethionine and/or salt thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59108799A (en) * | 1982-12-14 | 1984-06-23 | Nippon Zeon Co Ltd | Preparation of novel s-adenosyl-l-methionine salt |
JPS60181095A (en) * | 1984-02-27 | 1985-09-14 | Nippon Zeon Co Ltd | Composition containing s-adenosyl-l-methionine, and its preparation |
JP2005229812A (en) * | 2004-02-17 | 2005-09-02 | Kohjin Co Ltd | Dried microorganism or microorganism extract comprising stabilized sam and method for producing the same |
-
2006
- 2006-01-25 JP JP2006016595A patent/JP5046077B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59108799A (en) * | 1982-12-14 | 1984-06-23 | Nippon Zeon Co Ltd | Preparation of novel s-adenosyl-l-methionine salt |
JPS60181095A (en) * | 1984-02-27 | 1985-09-14 | Nippon Zeon Co Ltd | Composition containing s-adenosyl-l-methionine, and its preparation |
JP2005229812A (en) * | 2004-02-17 | 2005-09-02 | Kohjin Co Ltd | Dried microorganism or microorganism extract comprising stabilized sam and method for producing the same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010007651A1 (en) * | 2008-07-15 | 2010-01-21 | リジェンティス株式会社 | Composition having anti-periodontal disease effect |
WO2013080265A1 (en) * | 2011-12-02 | 2013-06-06 | 磐田化学工業株式会社 | Stabilization of s-adenosylmethionine with acid sodium metaphosphate |
WO2013146687A1 (en) * | 2012-03-30 | 2013-10-03 | ライオン株式会社 | Composition comprising s-adenosylmethionine and/or salt thereof |
Also Published As
Publication number | Publication date |
---|---|
JP5046077B2 (en) | 2012-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schulte-Frohlinde et al. | Radiolysis of DNA and model systems in the presence of oxygen | |
JP5046077B2 (en) | Method for stabilizing S-adenosylmethionine | |
Taklimi et al. | Effects of deep eutectic solvents on the activity and stability of enzymes | |
ES2406412T3 (en) | Dry, lyophilized and / or microencapsulated Saccharomyces cerevisiae cells with a high content of (S) - (+) - S-adenosyl-methionine | |
CN105001289A (en) | Eprinomectin refining method | |
FR3064269A1 (en) | PROCESS FOR THE PREPARATION OF A LIQUID EXTRACT OF PHYCOBILIPROTEINS, IN PARTICULAR PHYCOCYANINE, FROM CYANOBACTERIA OR MICROALOGUES AND EXTRACT THUS OBTAINED | |
Tandon et al. | Effect of sanguinarine on the transport of essential nutrients in an everted gut sac model: role of Na+, K+‐ATPase | |
EP2557151B1 (en) | S-adenosyl-l-methionine-containing dry yeast composition with excellent storage stability and process for producing same | |
CN105288652A (en) | Superoxide dismutase microcapsule powder and preparation method thereof | |
Seger et al. | Physicochemical properties of oosporein, the major secreted metabolite of the entomopathogenic fungus Beauveria brongniartii | |
PT1664317E (en) | Use of precursor z for the production of a means for therapy of human molybdenum cofactor deficiency | |
KR101330352B1 (en) | Method of stabilizing s-adenosyl-l-methionine and stabilized composition | |
RU2476217C2 (en) | Method of quercetin stabilisation | |
JP4707811B2 (en) | Dehydration stress protective agent | |
KR100845463B1 (en) | Extracting Method of Mushroom Extract, Mushroom Extract Extracted by it and Therapeutic/Preventive Agent for Osteoporosis Containing Mushroom Extract | |
RU2019110218A (en) | New compositions based on furazidine and methods for their manufacture | |
Veremeeva et al. | Novel amphiphilic compounds for the design of stimulus-sensitive liposomal containers | |
CA3137265A1 (en) | A stable, ready to use aqueous pharmaceutical composition of pemetrexed | |
FR2690340A1 (en) | Stabilisation of aq. pharmaceuticals - by addn. of citric acid and opt. metal phosphate | |
GT200400072A (en) | COMPOSITION OF WATERPROOF AGROCHEMICAL SUSPENSION. | |
Gibson et al. | Effects of diuretics on microsomal (Na+, K+)-ATPase in the human heart and the rat heart and kidney | |
JP2010091398A (en) | Stable natriuretic peptide composition | |
EP2340020B1 (en) | Manganese and cobalt complexes, their preparation and use | |
CN107080735A (en) | A kind of Indomethacin powder | |
Ren et al. | Photocatalytic inactivation mechanism of nano-BiPO4 against Vibrio parahaemolyticus and its application in abalone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090114 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111208 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111220 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120220 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120605 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120705 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150727 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |